PubMed-compiled information sheet
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 30 PubMed articles · model: gemma4:31b
Summary
Background
Traditional uses
Active compounds
Mechanism of action
Clinical evidence
Magnolia Volatile Oil (MVO) is reported to have therapeutic effects on allergic rhinitis [PMID:38441019].
M. biondii flower extract attenuates UVB-induced skin damage through high-mobility group box protein B1 [PMID:38685711].
Total lignans from M. biondii dose-dependently alleviated AD-like symptoms in mice by reducing epidermal hyperplasia and suppressing Il1b, Ccl5, and Ccl22 [PMID:42031117].
M. biondii extract showed protective effects against ligature-induced periodontitis in rats [PMID:31027223].
Water extract reduced mortality in LPS-challenged septic mice and attenuated pro-inflammatory mediators [PMID:35795403].
Evidence summary
PubMed sources
- 1.PMID: 38685711 (2024) — Magnolia biondii flower extract attenuates UVB-induced skin damage through high-mobility group box protein B1. · International journal of cosmetic science
- 2.PMID: 36395104 (2023) — New furofuran and tetrahydrofuran lignans from the flower buds of Magnolia biondii Pamp and their antiallergic effects. · Natural product research
- 3.PMID: 29760330 (2018) — Variations in Volatile Oil Yield and Composition of "Xin-yi" (Magnolia biondii Pamp. Flower Buds) at Different Growth Stages. · Journal of oleo science
- 4.PMID: 33098637 (2021) — Structural elucidation and neuroprotective activities of lignans from the flower buds of Magnolia biondii Pamp. · Zeitschrift fur Naturforschung. C, Journal of biosciences
- 5.PMID: 40508400